An Alzheimer's disease hypothesis based on transcriptional dysregulation

References

• Selkoe D J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741–766
   PubMed Web of Science ®Google Scholar
• Robakis N K, Ramakrishna N, Wolfe G, Wisniewski H M. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci USA. 1987; 84: 4190–4194
   PubMed Web of Science ®Google Scholar
• Goldgaber D, Lerman M I, McBride O W, Saffiotti U, Gajdusek D C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 1987; 235: 877–880
   PubMed Web of Science ®Google Scholar
• Kang J, Lemaire H G, Unterbeck A, Salbaum J M, Masters C L, Grzeschik K H, Multhaup G, Beyreuther K, Muller‐Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell‐surface receptor. Nature 1987; 325: 733–736
   PubMed Web of Science ®Google Scholar
• Tanzi R E, McClatchey A I, Lamperti E D, Villa‐Komaroff L, Gusella J F, Neve R L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 1988; 331: 528–530
   PubMed Web of Science ®Google Scholar
• Anderson J P, Esch F S, Keim P S, Sambamurti K, Lieberburg I, Robakis N K. act cleavage site of Alzheimer amyloid precursor in neuronal PC‐12 cells. Neurosci Lett 1991; 128: 126–128
   PubMed Web of Science ®Google Scholar
• Wang R, Meschia J F, Cotter R J, Sisodia S S. Secretion of the betal A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J Biol Chem 1991; 266: 16960–16964
   PubMed Web of Science ®Google Scholar
• Seubert P, Oltersdorf T, Lee M G, Barbour R, Blomquist C, Davis D L, Bryant K, Fritz L C, Galasko D, Thal L J, Lieberburg I, Schenk D B. Secretion of beta‐amyloid precursor protein cleaved at the amino terminus of the beta‐amyloid peptide. Nature 1993; 361: 260–263
   PubMed Web of Science ®Google Scholar
• Evin G, Cappai R, Li Q X, Culvenor J G, Small D H, Beyreuther K, Masters C L. Candidate gamma‐secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin. D. Biochemistry 1995; 34: 14185–14192
   PubMed Web of Science ®Google Scholar
• Glenner G G, Wong C W. Amyloidogenesis in Alzheimer's disease and Down's Syndrome. Cold Spring Harbor Press, Cold Spring Harbor, NY 1997; 53–265, Banbury Report 27, Mol. Neuropath. Aging
   Google Scholar
• Hardy J, Higgins G A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256: 184–185
   PubMed Web of Science ®Google Scholar
• Rozemuller J M, Eikelenboom P, Stam F C, Beyreuther K, Masters C L. A4 protein in Alzheimer's disease: primary, and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 1989; 48: 674–694
   PubMed Web of Science ®Google Scholar
• Robakis N K, Pangalos M N. Involvement of amyloid as a central step in the development of Alzheimer's disease. Neurobiol Aging 1994; 15: S127–129
   Web of Science ®Google Scholar
• Neve R L, Robakis N K. Alzheimer's disease: areexamination of the amyloid hypothesis. Trends Neurosci 1998; 21: 15–19
   PubMed Web of Science ®Google Scholar
• Smith M A, Joseph J A, Perry G. Arson: Tracking the culprit in Alzheimer's disease. Ann NY Acad Sci 2000; 924: 35–38
   PubMed Web of Science ®Google Scholar
• Robinson S R, Bishop G M. AP as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol Aging 2002; 23: 1051–1072
   PubMed Web of Science ®Google Scholar
• Hsia A Y, Masliah E, McConlogue L, Yu G O, Tatsuno G, Hu K, Kholodenko D, Malenka R C, Nicoll R A, Mucke L. Plaque‐independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA 1999; 96: 3228–3233
   PubMed Web of Science ®Google Scholar
• Mucke L, Masliah E, Yu G Q, Mallory M, Rockenstein E M, Tatsuno G, Hu K, Kholodenko D, Johnson‐Wood K, McConlogue L. High‐level neuronal expression of abeta 1–42 in wild‐type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000; 20: 4050–4058
   PubMed Web of Science ®Google Scholar
• Phinney A L, Deller T, Stalder M, Calhoun M E, Frotscher M, Sommer B, Staufenbiel M, Jucker M. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci 1999; 19: 8552–8559
   PubMed Web of Science ®Google Scholar
• Chui D H, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki P, Araki W, Inoue H, Shirotani K, Talahashi K, Gallyas F, Tabira T. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med 1999; 5: 560–564
   PubMed Web of Science ®Google Scholar
• DeWitt D A, Silver J. Regenerative failure: a potential mechanism for neuritic dystrophy in Alzheimer's disease. Exp Neurol 1996; 142: 103–110
   PubMed Web of Science ®Google Scholar
• Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L. Clinicopathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988; 38: 1682–1687
   PubMed Web of Science ®Google Scholar
• Arriagada P V, Growdon J H, Hedley‐Whyte E T, Hyrnan B T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631–639
   PubMed Web of Science ®Google Scholar
• Davis D G, Schrnitt F A, Wekstein D R, Markesbery W R. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999; 58: 376–388
   PubMed Web of Science ®Google Scholar
• Roberts G W, Gentleman S M, Lynch A, Murray L, Landon M, Graham D I. 2‐Amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Nesirosurg Psychiatry 1994; 57: 419–425
   PubMed Web of Science ®Google Scholar
• Graham D I, Gentleman S M, Lynch A, Roberts G W. Distribution of β‐amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol 1995; 21: 27–34
   PubMed Web of Science ®Google Scholar
• De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Gundula G, Annaert W, Von Figura K, Van Leuven F. Deficiency of presenilin‐1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391: 387–390
   PubMed Web of Science ®Google Scholar
• Wolfe M S, Xia W, Ostaszewski B L, Diehl T S, Kimberly W T, Selkoe D J. Two transmembrane aspartates in presenilin‐1 required for presenilin endoproteolysis and γ‐secretase activity. Nature 1999; 398: 513–517
   PubMed Web of Science ®Google Scholar
• Murayama O, Tomita T, Nihonmatsu N, Murayama M, Sun X, Honda T, Iwatsubo T, Takashima A. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. Neurosci Lett 1999; 265: 61–63
   PubMed Web of Science ®Google Scholar
• Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson‐Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strorne R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George Hyslop P, Selkoe D J. Mutant presenilins of Alzheimer's disease increase production of 42‐residue amyloid beta‐protein in both transfected cells and transgenic mice. Nat Med 1997; 3: 67–72
   PubMed Web of Science ®Google Scholar
• Walsh D M, Klyubin I, Fadeeva J V, Cullen W K, Anwyl R, Wolfe M S, Rowan M J, Selkoe D J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long‐term potentiation in vivo. Nature 2002; 416: 535–539
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe D J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353–356
   PubMed Web of Science ®Google Scholar
• Kunicki S, Richardson J, Mehta P D, Kim K S, Zorychta E. The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid‐2 (A2) 40, A2 42, apolipoprotein E., and transthyretin in human cerebrospinal fluid. Clin Biochem 1998; 31: 409–415
   PubMed Web of Science ®Google Scholar
• Shoji M, Matsubara E, Kanai M, Watanabe M, Nakamura T, Tomidokoro Y, Shizuka M, Wakabayashi K, Igeta Y, Ikeda Y, Mizushima K, Amari M, Lshiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, Hirai S. Combination assay of CSF tau, Aβ1–40 and Aβ1–42(43) as a biochemical marker of Alzheimer's disease. J Neurol Sci 1998; 158: 134–140
   PubMed Web of Science ®Google Scholar
• Hyman B T, Trojanowski J Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 1095–1097
   PubMed Web of Science ®Google Scholar
• Crystal H A, Dickson D, Davies P, Masur D, Grober E, Lipton R B. The relative frequency of dementia of unknown etiology increases with age and is nearly 50% in nonagenarians. Arch Neurol 2002; 57: 713–719
   Google Scholar
• Freiman R N, Tjian R. Neurodegeneration. A glutamine‐rich trail leads to transcription factors. Science 2002; 296: 2149–2150
   PubMed Web of Science ®Google Scholar
• Ross C A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002; 35: 819–822
   PubMed Web of Science ®Google Scholar
• Fortini M E. Gamma‐secretase‐mediated proteolysis in cell‐surface‐receptor signalling. Nat Rev Mol Cell Biol 2002; 3: 673–684
   PubMed Web of Science ®Google Scholar
• De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm J S, Schroeter E H, Schrijvers V, Wolfe M S, Ray W J, Goate A, Kopan R. A presenilin‐1‐dependent gamma‐secretase‐like protease mediates release of Notch intracellular domain. Nature 1999; 398: 518–522
   PubMed Web of Science ®Google Scholar
• Chen F, Gu Y, Hasegawa H, Ruan X, Arawaka S, Fraser P, Westaway D, Mount H, St George‐Hyslop P. Presenilin 1 mutations activate gamma 42‐secretase but reciprocally inhibit epsilon‐secretase cleavage of arnyloid precursor protein (AβPP) and S3‐cleavage of notch. J Biol Chem 2002; 277: 36521–36526
   PubMedGoogle Scholar
• Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nanj V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis N K. A presenilin‐ 1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002; 21: 1948–1956
   PubMed Web of Science ®Google Scholar
• Lee H J, Jung K M, Huang Y Z, Bennett L B, Lee J S, Mei L, Kim T W. Presenilin‐dependent gamma‐secretase‐like intramembrane cleavage of Erb B4. J Biol Chem 2002; 277: 6318–6323
   PubMed Web of Science ®Google Scholar
• Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, Wong A J, Saya H. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 2001; 155: 755–762
   PubMed Web of Science ®Google Scholar
• Lammich S, Okochi M, Takeda M, Kaether C, Capell A, Zimmer A K, Edbauer D, Walter J, Steiner H, Haass C. Presenilin‐dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta‐like peptide. J Biol Chem 2002; 277: 44754–44759
   PubMed Web of Science ®Google Scholar
• May P, Reddy Y K, Herz J. Proteolytic processing of low density lipoprotein receptor‐related protein mediates regulated release of its intracellular domain. J Biol Chem 2002; 277: 18736–18743
   PubMed Web of Science ®Google Scholar
• Kim D Y, Lngano L A, Kovacs D M. Nectin‐lalpha, an immunoglobulin‐like receptor involved in the formation of synapses, is a substrate for presenilinigamma ‐secretase‐like cleavage. J Biol Chem 2002; 277: 49976–49981
   PubMed Web of Science ®Google Scholar
• Baek S H, Ohgi K A, Rose D W, Koo E H, Glass C K, Rosenfeld M G. Exchange of N‐CoR corepressor and Tip60 coactivator complexes links gene expression by NF‐kappaB and beta‐amyloid precursor protein. Cell 2002; 110: 55–67
   PubMed Web of Science ®Google Scholar
• Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, Kaether C, Zheng H, Ghetti B, Haass C, Steiner H. Presenilin‐1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci USA 2002; 99: 8025–8030
   PubMed Web of Science ®Google Scholar